INS and obesity due to melanocortin 4 receptor deficiency: In the Look AHEAD study, participants with overweight, obesity, and T2DM, with BMI > 25 kg/m2 or > 27 kg/m2 if receiving insulin and an age range of 45–76, were randomized to lifestyle intervention (ILI) or diabetes support and education.